LLY and CNTA Related Headlines
Go Back- Centessa shares surge after Lilly unveils $6.3 billion takeover deal
- Lilly to acquire Centessa for $6.3 billion to expand sleep disorder treatments
- Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
- Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'
- FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'
